CXCL12 and neoplasm: CEBPB is an important cytokines response transcription factor, the chemokines CXCL12 induced recruitment of Tregs via CEBPB/NF-κB signaling to promote drug resistance [79], thus the inhibition of CEBPB benefited the tumor treatment.